BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04191135-completion@plaintrial.com
DTSTAMP:20261029T024419Z
DTSTART;VALUE=DATE:20251126
SUMMARY:Study of Olaparib Plus Pembrolizumab Versus Chemotherapy Plus Pembr
 olizumab After Induction With First-Line Chemotherapy Plus Pembrolizumab i
 n Triple Negative Breast Cancer (TNBC) (MK-7339-009/KEYLYNK-009) — estim
 ated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT04191135
URL:https://plaintrial.com/trial/NCT04191135
END:VEVENT
END:VCALENDAR